Table 2.
The clinical application of DC vaccines.
| Tumor types | Phase | Status | Participants | Source of DCs | NCT number |
|---|---|---|---|---|---|
| Breast Cancer | Phase I/II | Completed | 10 | / | NCT02018458 |
| Breast Cancer | Phase I/II | Completed | 44 | / | NCT01042535 |
| Unspecified Adult Solid Tumor | |||||
| Breast Cancer | Phase I | Completed | 31 | monocytes | NCT00978913 |
| Malignant Melanoma | |||||
| Colorectal Cancer | Phase I | Completed | 6 | monocytes | NCT01671592 |
| Lung Cancer | Phase II | Completed | 32 | white blood cells | NCT00103116 |
| Prostate Cancer | Phase II | Completed | 13 | / | NCT00970203 |
| Hematological Malignancies | Phase I/II | Completed | 10 | / | NCT02528682 |
| Gastric Cancer | Phase I/II | Recruiting | 45 | / | NCT04567069 |
| Colorectal Cancer | Phase I | Recruiting | 12 | / | NCT03730948 |
| Glioblastoma | Phase II/III | Recruiting | 60 | / | NCT03548571 |
| Breast Cancer | Phase I | Active, not recruiting | 15 | / | NCT02063724 |